HYPERTENSION IN THYROTOXICOSIS AND ITS IMPACT ON LEFT VENTRICULAR HYPERTROPHY
https://doi.org/10.18705/1607-419X-2013-19-3-237-241
Abstract
Objective. We present the results of the study assessing the frequency and character of hypertension in thyrotoxicosis, and its impact on left ventricular remodeling and cardiovascular prognosis.
Results and conclusions. Our data demonstrated that hypertension, and predominantly systolic hypertension, is highly prevalent in thyrotoxicosis and affects left ventricular remodeling. All normotensive patients developed only eccentric left ventricular hypertrophy (LVH). The prevalence of LVH, and of its concentric forms increases with the elevation of blood pressure. Concentric LVH is associated with the high rate of atrial fi brillation and heart failure.
About the Authors
A. Yu. Babenko
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
Corresponding author: Almazov Federal Heart, Blood and Endocrinology Centre, 15 Parkhomenko av., St Petersburg, Russia, 194156. Phone/fax: 8 (812) 702–55–95. E-mail: alina_babenko@mail.ru (Alina Yu. Babenko, MD, PhD, the Нead of the Research Laboratory of Cardiovascular Complications of Type 2 Diabetes Mellitus at Almazov Federal Heart, Blood and Endocrinology Centre).
E. N. Grineva
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
V. N. Solntsev
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
References
1. Левина Л.И. Сердце при эндокринных заболеваниях. — Ленинград: «Медицина», 1983. — С. 62–108. / Levina L.I. Heart in endocrine diseases. — Leningrad: «Medicine», 1983. — P. 62–108 [Russian].
2. Marcisz C., Jonderko G., Kucharz E.J. Infl uence of shorttime application of low sodium diet on blood pressure in patients with hyperthyroidism or hypothyroidism during therapy // Am. J. Hypertens. — 2001. — Vol. 14, № 10. — Р. 995–1002.
3. Vargas F., Moreno J.M., Rodríguez-Gómez I. et al. Vascular and renal function in experimental thyroid disorders // Eur. J. Endocrinol. — 2006. — Vol. 154, № 2. — Р. 197–212.
4. Klein I., Levey G.S. The cardiovascular system in thyrotoxicosis / In: Braverman L.E. Utiger R.D., eds. The thyroid. — 8th ed. — Philadelphia: Lippincott-Raven, 2000. — Р. 596–604.
5. Klein I., Ojamaa K. Thyroid hormone and cardiovascular system // N. Engl. J. Med. — 2001. — Vol. 344, № 7. — Р. 501- 509.
6. Palmieri E.A., Fazio S., Palmieri V., Lombardi G., Biondi B. Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade // Eur. J. Endocrinol. — 2004. — Vol. 150, № 6. — Р. 757–762.
7. Botella-Carretero J.I., Gómez-Bueno M., Barrios V. et al. Chronic thyrotropin-suppressive therapy with levothyroxine and shortterm overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma // Endocr. Relat. Cancer. — 2004. — Vol. 11, № 2. — Р. 345–356.
8. Джанашия П.Х., Селиванова Г.Б. Анализ степени тяжести артериальной гипертензии и состояния липидного спектра крови при тиреотоксикозе и гипотиреозе // Рос. кардиологич. журн. — 2004. — № 4. — [Электронный ресурс]. — URL: http:// medi.ru/doc/6640405.htm. / Dzhanashiya P.Kh., Selivanova G.B. Analysis of hypertension severity and lipid metabolism in thyrotoxicosis and hypothyroidism // Russian Cardiology Journal [Rossiyskiy Kardiologicheskiy Zhurnal]. — 2004. — № 4. — [Electronic resource]. — URL: http://medi.ru/doc/6640405.htm.
9. Рекомендации по профилактике, диагностике и лечению артериальной гипертензии / В кн. «Кардиология», краткое руководство по кардиологии под редакцией академика РАМН Ю.П. Никитина, издание второе, измененное и дополненное. — Новосибирск, 2001. — 29 с. / Guidelines on prevention, diagnosis and treatment of hypertension / In: Cardiology, textbook on cardiology ed. by academician of RAMS Yu.P. Nikitin. — 2nd ed., added and changed. — Novosibirsk, 2001. — 29 p. [Russian].
10. Lang R.M., Bierig M., Devereux R.B. et al. Recommendations for chamber quantifi cation: a report from the American of Society Echocardiography's guidelines and standards committee and the chamber quantifi cation writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology // J. Am. Soc. Echocardiogr. — 2005. — Vol. 18, № 12. — Р. 1440–1463.
11. De Simone G. Concentric or eccentric hypertrophy: how clinically relevant is the difference? // Hypertension. — 2004. — Vol. 43, № 4. — P. 714–715.
Review
For citations:
Babenko A.Yu., Grineva E.N., Solntsev V.N. HYPERTENSION IN THYROTOXICOSIS AND ITS IMPACT ON LEFT VENTRICULAR HYPERTROPHY. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2013;19(3):237-241. (In Russ.) https://doi.org/10.18705/1607-419X-2013-19-3-237-241
Views:
6541
Email this article 